In addition, the FDAs Pharmacy Compounding Advisory Committee will consider another five peptides for compounding-pharmacy approval before the end of February 2027: Cathelicidin (LL-37) GHK-Cu Dihexa acetate Melanotan II Pegylated Mechano Growth Factor (PEG-MGF) Which peptides are you hearing the most about in sports medicine
Unlike retinoids that increase photosensitivity, GHK-Cu provides UV protection
Dihexa activates the HGF/c-Met receptor pathway, which stimulates synaptogenesis the formation of new synaptic connections between neurons
A placebo-controlled, dose-ranging study of a growth hormone releasing factor in HIV-infected patients with abdominal fat accumulation
Depending on the peptide, they may support growth hormone production, recovery, metabolism, tissue repair, healthy aging, or overall wellness
The results are usually temporary and the procedure will need to be repeated as needed.